What we are studying
It is estimated that 84% of head and neck cancer patients smoking at the time of their diagnosis will quit smoking without any specialized help, but unfortunately about 60% of patients will re-start smoking after treatment finishes. It is so important for your health to be able to not smoke again and we want to see if there are treatments that are better than others to help you not re-start smoking. Many patients feel anxious and depressed while taking treatment for their head and neck cancer and later while recovering from treatment, and we want to compare a medication that can also help with depression signs called bupropion (Zyban®) with other treatments known to help patients to stop smoking and to stay away from re-starting smoking. All medications used in this study are approved by FDA as strategies to help with quitting smoking.
Parking validation for study related office visits